Contact Us
Find A Doctor

Mycophenolate Mofetil Chronic Non-Infectious Uveitis Treatment Study

Principal Investigator

C. Michael Samson, M.D.

Enrollment Status



To determine if CellCept is as effective or more effective than Methotrexate in treating uveitis. This is a randomized, masked, controlled comparative trial against Methotrexate.


The data generates concordant evidence with other SUN-compliant studies supporting the use of Mycophenolate Mofetil in uveitis.

For more information:

Contact Us

Dr. C. Michael Samson, Principal Investigator

Katy Tai, Research ManagerTel: (212) 979-4251

Address310 E. 14th StreetNew York, NY 10003

View all locations